03/21/2022 | Andrzej Grzybowski
Tadeusz Krwawicz: the hero of cataract cryoextraction
03/17/2022 | Ningli Wang
Despite pandemic-related challenges, my team have managed to make promising progress in glaucoma research, with a few major breakthroughs
03/15/2022 | Dan Lindfield
Two recent updates in the glaucoma field that are definitely worth shouting about
03/14/2022 | Aleksandra Jones
A dislocated IOL captured by Merritt Gammage
03/11/2022 | Geoffrey Potjewyd
For the first time, the development of the eye is tracked in real time at a cellular level
03/10/2022 | Geoffrey Potjewyd
Can we repair the visual and cognitive damage caused by long COVID?
03/08/2022 | Oscelle Boye
Researchers probe the origin of spaceflight-associated neuro-ocular syndrome
03/07/2022 | Geoffrey Potjewyd
How do you convince your droid to switch to an artificial retina?
03/04/2022 | Ivan Gabrić
Can hybrid IOLs, combining EDoF and diffractive multifocal options, be the right choice for presbyopes?
03/03/2022 | Sponsored by Kala Pharmaceuticals
Kala’s innovative drug delivery technology is designed to enhance efficacy, empowering eye care professionals with a short-term Rx treatment
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Access All Areas: Recognizing Global Education Impact 2024
POAG Preferences
The Future-Ready Surgeon
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: